Abstract
The chronicle use of nitrogen containing bisphosphonates (nBP) for the treatment of bone metabolism diseases and disorders, such osteoporosis, is a therapeutic treatment well established, mainly involving patients at age over to 60 years old. However, this treatment is also related to the development of Osteonecrosis of Jaw (ONJ), and the risk of ONJ occurrence increase after surgical and…